LAMC2

gene product
BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa
Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
257 antibodies from 30 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
2 antibodies
antibodies-online
60 antibodies
Santa Cruz Biotechnology
1 antibody
LifeSpan BioSciences, Inc.
85 antibodies
Aviva Systems Biology
7 antibodies
Biorbyt
6 antibodies
Boster Biological Technology
1 antibody
GeneTex
1 antibody
Novus Biologicals
1 antibody
NSJ Bioreagents
1 antibody
OriGene
1 antibody
Invitrogen Antibodies
4 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Signalway Antibody LLC
1 antibody
Affinity Biosciences
1 antibody
NovoPro Bioscience Inc.
1 antibody
Proteintech Group
1 antibody
MyBioSource
17 antibodies
EMD Millipore
4 antibodies
Abnova Corporation
1 antibody
Creative Biolabs
7 antibodies
St John's Laboratory
2 antibodies
Abbexa
1 antibody
Bioworld Technology, Inc
1 antibody
RabMAbs
1 antibody
United States Biological
39 antibodies
Creative Diagnostics
1 antibody
Sigma-Aldrich
1 antibody
GenWay
6 antibodies
ProSci
1 antibody